is part of the Global Exhibitions Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Mass spectrometry has historically been limited to research laboratories, but the advent of soft ionization techniques such as electrospray ionization (ESI) and matrix assisted laser desorption ionization (MALDI) in the late 1980s
Breakthroughs in cutting-edge, experimental treatments using new pharmaceuticals or procedures often dominate healthcare news.
Anti-nuclear antibody (ANA) testing is a cornerstone of autoimmune diagnostics. ANA occur in a variety of autoimmune diseases, including systemic autoimmune rheumatic diseases (SARD), systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD)
With 253 exhibitors, 10 country pavilions, 29 exhibiting countries and 4,025 attendees – constituting a 60% increase in visitor turnout compared to the 2016 edition.
The field of laboratory medicine has undergone numerous changes over the last few years. Automation has become an essential part
Medical laboratories, whether in hospitals or in freestanding locations, have complex operations and procedures that require physical contact with patient samples and reagents.
Over a decade ago, predictions were made about the rapid growth of data on the World Wide Web, and the ability to gain meaningful insight from this information.
Only a few years ago the term digital pathology implied a static snapshot obtained from a digital camera mounted on a conventional microscope, and telepathology implied remotely viewing a microscope slide via an analogue camera.
Moving towards consolidation, standardisation and automation in the laboratory to tackle today’s challenges and tomorrow’s complex healthcare landscape.
Autoantibody determination plays an important role in the diagnosis and differentiation of autoimmune bullous dermatoses (AIBD). Various autoantibodies against skin structures can be detected by serological methods such as indirect immunofluorescence (IIF) and ELISA.
Arboviruses, or arthropod-borne viruses, are on the march globally. Increased urbanisation and international travel facilitate the spread of mosquito vectors and hence the viral diseases they carry.
Sexually transmitted infections (STIs) are a major and growing health problem in all parts of the world. According to the World Health Organisation (WHO) more than one million STIs are acquired worldwide every day. Untreated, they can lead to serious long-term sequelae, especially infertility.
Advances in medicine in the 17th century provided the foundation for diagnostic laboratory testing. The discovery of the circulation of blood by William Harvey and subsequent development of procedures to withdraw blood from a patient's vein for therapeutic purposes have enabled physicians to utilise blood to detect and monitor disease.
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are distinct genetic disorders caused by lack of expression of paternally (PWS) or maternally (AS) imprinted genes in the 15q11–15q13 region, which is known as the Prader-Willi/Angelman syndrome critical region (PWASCR).
Since the announcement of the first working draft of the Human Genome on June 26, 2000, then President of the United States, Mr Bill Clinton had declared, “Genome Science will have a real impact on our lives - and even more, on the lives of our children.